Announces CAEL-101 Strategic Partnership with Alexion Pharmaceut

Fortress-founded Caelum Biosciences to receive $60 million in a strategic equity investment and option fee

Alexion has option to acquire Caelum Biosciences based on Phase 2 data

finance.yahoo.c...-113000172.html?.tsrc=rss